Search results
Beximco Pharmaceuticals Ltd Stock forecast & analyst price target predictions, earnings, revenue ,EPS predictions, upgrades and downgrades. 🚀 Enjoy a 7-Day Free Trial Thru Oct 10, 2024! Sign Up
May 9, 2024 · Future criteria checks 2/6. Beximco Pharmaceuticals is forecast to grow earnings and revenue by 15.6% and 12.8% per annum respectively. EPS is expected to grow by 18.3% per annum. Return on equity is forecast to be 14.8% in 3 years.
View today's Beximco Pharmaceuticals Ltd stock price and latest BXPH news and analysis. Create real-time notifications to follow any changes in the live stock price.
What is Beximco Pharmaceuticals Earnings Per Share? The Beximco Pharmaceuticals EPS is 11.95. Access detailed information about the Beximco Pharmaceuticals Ltd (BXPH) Share including Price, Charts, Technical Analysis, Historical data, Beximco Pharmaceuticals Reports and more.
Aug 21, 2024 · Investment Themes Homepage; Private Equity ... 2022 2023 2024 ... Cash Flow Forecast: Beximco Pharmaceuticals Limited. Fiscal Period: June 2019
BLOOMBERG: BXPHAR:BD. damentalsBeximco Pharmaceuticals Limited (BXPHARMA) commenced its manufacturing operatio. in 1980. The Company is engaged in manufacturing and marketing of generic pharmaceuticals formulation products including life-saving intravenous fluids and Active Pharmaceuticals Ingredients (APIs) for both national and internation.
5 days ago · 1976. n/a. n/a. www.beximcopharma.com. Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine ...
